Expectations and experience: Parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expectations and experience: Parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID)

Published:2021-08 Issue: Volume:229 Page:108778
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Smith Heather,Scalchunes Christopher,Cowan Morton J.,Puck Jennifer,Heimall Jennifer

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference21 articles.

1. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the primary immune deficiency treatment consortium experience;Shearer;J. Allergy Clin. Immunol.,2014

2. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee;Tangye;J. Clin. Immunol.,2020

3. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification;Bousfiha;J. Clin. Immunol.,2020

4. Immunological reconstitution of sex-linked lymphopenic immunological deficiency;Gatti;Lancet.,1968

5. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival;Myers;Blood.,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3